BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29045018)

  • 21. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
    Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
    BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of surgical treatment for esthesioneuroblastomas: 31-Year experience at a single institution.
    Hwang CS; Seo YW; Park SC; Chung HJ; Cho HJ; Yoon JH; Kim CH
    J Craniomaxillofac Surg; 2017 Jan; 45(1):120-126. PubMed ID: 27840119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An atypical Esthesioneuroblastoma of the sphenoid sinus: a case report.
    Touihmi S; Horrane I; Rkain I
    Ann Med Surg (Lond); 2023 May; 85(5):2029-2033. PubMed ID: 37228980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and overall survival in pediatric versus adult esthesioneuroblastoma: A population-based study.
    Berger MH; Lehrich BM; Yasaka TM; Fong BM; Hsu FPK; Kuan EC
    Int J Pediatr Otorhinolaryngol; 2021 May; 144():110696. PubMed ID: 33812144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
    Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
    Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma.
    De Bonnecaze G; Chaput B; Al Hawat A; Filleron T; Vairel B; Serrano E; Vergez S
    Acta Otolaryngol; 2014 Dec; 134(12):1259-64. PubMed ID: 25399885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
    Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
    Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of esthesioneuroblastoma treatment delays on overall patient survival.
    Tsutsumi K; Ahmed KH; Goshtasbi K; Torabi SJ; Mohyeldin A; Hsu FPK; Kuan EC
    Laryngoscope; 2023 Apr; 133(4):764-772. PubMed ID: 35460271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttreatment prognosis of patients with esthesioneuroblastoma.
    Kane AJ; Sughrue ME; Rutkowski MJ; Aranda D; Mills SA; Buencamino R; Fang S; Barani IJ; Parsa AT
    J Neurosurg; 2010 Aug; 113(2):340-51. PubMed ID: 20345216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible esthesioneuroblastoma metastasis to paranasal sinuses: Clinical report and literature review.
    Buohliqa L; Upadhyay S; Nicolai P; Cavalieri R; Dolci RL; Prevedello D; Carrau RL
    Head Neck; 2016 Feb; 38(2):E32-6. PubMed ID: 25946111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of intracranial metastatic esthesioneuroblastoma.
    Chamberlain MC
    Cancer; 2002 Jul; 95(2):243-8. PubMed ID: 12124822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esthesioneuroblastoma: 25-year experience at a single institution.
    Zafereo ME; Fakhri S; Prayson R; Batra PS; Lee J; Lanza DC; Citardi MJ
    Otolaryngol Head Neck Surg; 2008 Apr; 138(4):452-8. PubMed ID: 18359353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical analysis of 34 cases of esthesioneuroblastoma].
    Liu WS; Tang PZ; Xu GZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical analysis of 49 cases of esthesioneuroblastoma].
    Mao M; Wang R; Wang H; Zhang X; Chen L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 49(3):210-3. PubMed ID: 24820490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis.
    Gallagher KK; Spector ME; Pepper JP; McKean EL; Marentette LJ; McHugh JB
    Ann Otol Rhinol Laryngol; 2014 May; 123(5):353-8. PubMed ID: 24668054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management.
    Sakata K; Maeda A; Rikimaru H; Ono T; Koga N; Takeshige N; Tokutomi T; Umeno H; Kiyokawa K; Morioka M
    World Neurosurg; 2016 May; 89():240-54. PubMed ID: 26875653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esthesioneuroblastoma: is there a need for elective neck treatment?
    Demiroz C; Gutfeld O; Aboziada M; Brown D; Marentette LJ; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e255-61. PubMed ID: 21676553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.